Skip to main content
    X

    XOMA Royalty Corporation (XOMAP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $24.98
    +0.00 (+0.00%)

    Last updated: Nov 06, 2026 at 4:00 PM ET

    Earnings

    Upcoming Estimates

    Results pendingPeriod ending Jun 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    $16.12M
    Range$16.12M - $16.12M
    1 analysts
    Results pendingPeriod ending Sep 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    $16.42M
    Range$16.42M - $16.42M
    1 analysts
    Last 12 of 30 reported quarters and 3 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    Date TBD
    -$0.30$0.05 - $0.57--4--
    Sep 26EST
    Date TBD
    -N/AN/A-----
    Jun 26EST
    Date TBD
    -N/AN/A-----
    Sep 25
    Reported Nov 12
    $0.70N/AN/A--0
    No revisions (30d)
    +171.4%
    Jun 25
    Reported Aug 15
    $0.44N/AN/A--0
    No revisions (30d)
    +168.8%
    Mar 25
    Reported May 13
    $0.06N/AN/A--0
    No revisions (30d)
    +112.5%
    Dec 24
    Reported Mar 17
    -$0.45N/AN/A--0
    No revisions (30d)
    +15.1%
    Mar 23
    Reported May 9
    -$0.98N/AN/A-----206.2%
    Dec 22
    Reported Mar 9
    -$0.64N/AN/A-----137.9%
    Sep 22
    Reported Nov 3
    -$0.48N/AN/A----+5.9%
    Jun 22
    Reported Aug 4
    -$0.53N/AN/A-----71.0%
    Mar 22
    Reported May 5
    -$0.32N/AN/A----+54.3%
    Dec 21
    Reported Mar 8
    $1.69N/AN/A----+32.0%
    Sep 21
    Reported Nov 4
    -$0.51N/AN/A-----410.0%
    Jun 21
    Reported Aug 5
    -$0.31N/AN/A----+6.1%

    Last ex-dividend: Jul 2, 2026

    Dividend Metrics

    Forward Yield8.63%
    Forward Annual Dividend$2.16
    Payout Ratio424.61%
    FrequencyQuarterly
    Pay MonthsJan, Apr, Jul

    Growth

    3Y CAGR+0.24%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA8.78x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin69.60%Operating Margin-3.90%
    ROE34.20%ROIC21.81%
    Financial Health
    Debt/Equity0.91xInterest Coverage3.55x
    Current Ratio3.59xQuick Ratio3.59x
    Trading Statistics
    Beta0.86Avg VolumeN/A
    52-Week High$26.7252-Week Low$24.52

    Technical Indicators Dashboard

    As of Nov 16, 2026, the 50-day average is below the 200-day average. The 14-day RSI is 54.3, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$24.98
    SMA 20$24.98
    SMA 50$24.98
    SMA 200$24.99
    EMA 10$24.98
    EMA 20$24.98
    EMA 50$24.98
    EMA 200$24.90

    MACD

    Line: 0.00Signal: 0.00Hist: N/A

    ADX

    ADX: 50.7+DI: 3.6-DI: 11.1

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down100.0
    PSAR$25.03

    Bollinger Bands

    Upper Band$24.98
    Lower Band$24.98
    %B PositionN/A
    Band Width0.50

    RSI (14-Day)

    Neutral
    54.3

    Momentum Oscillators

    Stoch %KN/A
    Stoch %DN/A
    Williams %RN/A
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)N/A
    MFI (14d)N/A

    Volatility Measures

    ATR (14d)$0.00(0.0%)
    StdDev (20d)N/A
    Hist VolN/A

    Volume Flow

    VWAP$24.98
    OBV-2.2K
    AD Line-449011406666.2B
    CMF (20d)N/A

    Volume Metrics

    Avg Vol (20d)N/A
    Vol RatioN/A
    VWMA (20d)N/A

    Pivot Points

    R3$24.98
    R2$24.98
    R1$24.98
    Pivot Point$24.98
    S1$24.98
    S2$24.98
    S3$24.98

    Advanced Oscillators

    TSI10.01
    Ultimate OscN/A
    KSTN/A

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about XOMAP

    News

    No news available

    Company news will appear here when available

    XOMAP Valuation

    GNG's valuation label for XOMAP is Fairly valued.

    EV/EBITDA
    8.8x
    P/B
    3.9x
    All XOMAP metrics

    XOMAP Profitability: Margins, ROIC and FCF

    XOMA Royalty (XOMAP) has a gross margin of 94.3%, an operating margin of -3.9% and a net margin of 69.6%. It posts 21.8% ROIC and a 23.8% FCF margin.

    Gross margin
    94.3%
    Operating margin
    -3.9%
    Net margin
    69.6%
    ROIC
    21.8%
    ROE
    34.2%
    FCF margin
    23.8%
    XOMAP financial statements

    XOMA Royalty Competitors

    The companies most similar to XOMA Royalty (XOMAP) include Omeros, OmniAb and eXoZymes.

    Sector: Healthcare

    XOMAP Bull Case vs Bear Case

    Bull case

    • XOMAP earns a 21.8% return on invested capital.
    • XOMAP converts 23.8% of revenue into free cash flow.
    • XOMAP has a 69.6% net profit margin.

    Bear case

    • XOMAP's quarterly revenue changed -22.6% year over year.

    XOMAP Dividend

    Forward yield
    8.6%
    Payout ratio
    424.6%
    3Y DPS growth
    0.2%
    Pay months
    Jan, Apr, Jul
    XOMAP dividend history

    Updated Jul 2, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About XOMAP

    When is XOMAP's next ex-dividend date?

    XOMAP has not declared its next regular ex-dividend date yet. Its last ex-dividend date was Jul 2, 2026 ($0.5391 per share). Over the last 12 months, XOMAP went ex-dividend in Jan, Apr and Jul.

    What is XOMAP's current dividend yield?

    XOMA Royalty Corporation (XOMAP) has a forward dividend yield of 8.63%.

    Does XOMAP pay dividends?

    Yes, XOMA Royalty Corporation pays dividends with a forward dividend yield of 8.63%.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.